Signaling lymphocytic activation molecule family 8 disrupts epithelial barrier in chronic rhinosinusitis with nasal

Danyang Li1, Longgang Yu1, Jiajia Zi1

  • 1Department of Otorhinolaryngology Head and Neck Surgery, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.

Abstract

Insights

Signaling lymphocytic activation molecule family (SLAMF)8 promotes M1 macrophage polarization in noneosinophilic chronic rhinosinusitis with nasal polyps (neCRSwNP). Targeting SLAMF8 may improve nasal epithelial barrier function and disease severity.

Area of Science:

  • Immunology and Inflammation Research
  • Epithelial Biology and Barrier Function
  • Rhinology and Sinonasal Diseases

Background:

  • M1 macrophages are prevalent in noneosinophilic chronic rhinosinusitis with nasal polyps (neCRSwNP), but regulatory mechanisms and epithelial impact are unknown.
  • Signaling lymphocytic activation molecule family (SLAMF)8, expressed in myeloid cells, is investigated for its role in M1 macrophage polarization and neCRSwNP pathogenesis.

Purpose of the Study:

  • To examine SLAMF8 expression in neCRSwNP.
  • To determine SLAMF8's role in M1 macrophage polarization.
  • To assess SLAMF8's contribution to nasal epithelial barrier dysfunction and epithelial-mesenchymal transition (EMT) in neCRSwNP.

Main Methods:

  • SLAMF8 expression was quantified in sinonasal tissues using RT-qPCR and Western blot.
  • Immunofluorescence confirmed SLAMF8 co-localization with macrophages.
  • SLAMF8 knockdown was performed in THP-1 cells, followed by co-culture with human nasal epithelial cells to assess M1 polarization, EMT, and tight junction integrity.

Main Results:

  • SLAMF8 was highly expressed on M1 macrophages in neCRSwNP tissues and correlated with disease severity.
  • SLAMF8 knockdown reduced M1 markers and inflammatory cytokine secretion.
  • Reduced SLAMF8 in M1 macrophages improved epithelial viability, decreased EMT and apoptosis, and restored tight junction proteins (occludin, claudin-4).

Conclusions:

  • Elevated SLAMF8 is linked to EMT, compromised epithelial tight junctions, and disease severity in neCRSwNP.
  • SLAMF8 promotes M1 macrophage polarization, contributing to epithelial barrier impairment.
  • SLAMF8 represents a potential therapeutic target for neCRSwNP.